| pubmed-article:9177306 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9177306 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:9177306 | lifeskim:mentions | umls-concept:C1513095 | lld:lifeskim |
| pubmed-article:9177306 | lifeskim:mentions | umls-concept:C0079284 | lld:lifeskim |
| pubmed-article:9177306 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:9177306 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:9177306 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:9177306 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9177306 | pubmed:dateCreated | 1997-7-10 | lld:pubmed |
| pubmed-article:9177306 | pubmed:abstractText | Expression of endothelin (ET) receptor subtypes was examined in an experimental model of A375 human melanoma cell differentiation using the pyrimidine analog bromodeoxyuridine (BUdR). BUdR (10 microM)-treated cells had an increased surface area and an increased dendricity, were contact-inhibited and lacked tumorigenecity in athymic nude mice. The untreated A375 cells exclusively expressed ETB and BUdR-induced phenotypical changes were accompanied by induction of ETA expression as evidenced by northern blotting, [125I]ET-1 binding assay and [Ca2+]i measurement. Thus, BUdR-induced differentiation of A375 melanoma cells may provide a model system to study the receptor subtype switch in melanocyte development. | lld:pubmed |
| pubmed-article:9177306 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9177306 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9177306 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9177306 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9177306 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9177306 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9177306 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9177306 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9177306 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9177306 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9177306 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9177306 | pubmed:month | May | lld:pubmed |
| pubmed-article:9177306 | pubmed:issn | 0006-291X | lld:pubmed |
| pubmed-article:9177306 | pubmed:author | pubmed-author:ImamuraSS | lld:pubmed |
| pubmed-article:9177306 | pubmed:author | pubmed-author:MasalaCC | lld:pubmed |
| pubmed-article:9177306 | pubmed:author | pubmed-author:OhtaniTT | lld:pubmed |
| pubmed-article:9177306 | pubmed:author | pubmed-author:NinomiyaHH | lld:pubmed |
| pubmed-article:9177306 | pubmed:author | pubmed-author:OkazawaMM | lld:pubmed |
| pubmed-article:9177306 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9177306 | pubmed:day | 19 | lld:pubmed |
| pubmed-article:9177306 | pubmed:volume | 234 | lld:pubmed |
| pubmed-article:9177306 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9177306 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9177306 | pubmed:pagination | 526-30 | lld:pubmed |
| pubmed-article:9177306 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:meshHeading | pubmed-meshheading:9177306-... | lld:pubmed |
| pubmed-article:9177306 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9177306 | pubmed:articleTitle | Bromodeoxyuridine-induced expression of endothelin A in A375 human melanoma cells. | lld:pubmed |
| pubmed-article:9177306 | pubmed:affiliation | Department of Pharmacology, Faculty of Medicine, Kyoto University, Japan. | lld:pubmed |
| pubmed-article:9177306 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9177306 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9177306 | lld:pubmed |
